- Home
- PODC vs CPIX Comparison
PODC vs CPIX Comparison
Compare PODC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- CPIX
- Stock Information
- Founded
- PODC 2013
- CPIX 1999
- Country
- PODC United States
- CPIX United States
- Employees
- PODC N/A
- CPIX N/A
- Industry
- PODC
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- PODC
- CPIX Health Care
- Exchange
- PODC Nasdaq
- CPIX Nasdaq
- Market Cap
- PODC 42.8M
- CPIX 43.8M
- IPO Year
- PODC N/A
- CPIX 2009
- Fundamental
- Price
- PODC $1.50
- CPIX $3.13
- Analyst Decision
- PODC
- CPIX
- Analyst Count
- PODC 0
- CPIX 0
- Target Price
- PODC N/A
- CPIX N/A
- AVG Volume (30 Days)
- PODC 62.2K
- CPIX 78.0K
- Earning Date
- PODC 08-13-2025
- CPIX 08-05-2025
- Dividend Yield
- PODC N/A
- CPIX N/A
- EPS Growth
- PODC N/A
- CPIX N/A
- EPS
- PODC N/A
- CPIX N/A
- Revenue
- PODC $53,954,000.00
- CPIX $42,071,813.00
- Revenue This Year
- PODC $17.91
- CPIX N/A
- Revenue Next Year
- PODC $14.41
- CPIX N/A
- P/E Ratio
- PODC N/A
- CPIX N/A
- Revenue Growth
- PODC 17.74
- CPIX 11.34
- 52 Week Low
- PODC $1.10
- CPIX $1.04
- 52 Week High
- PODC $2.94
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- PODC 36.51
- CPIX 44.65
- Support Level
- PODC $1.50
- CPIX $2.75
- Resistance Level
- PODC $1.69
- CPIX $3.49
- Average True Range (ATR)
- PODC 0.16
- CPIX 0.35
- MACD
- PODC 0.00
- CPIX -0.02
- Stochastic Oscillator
- PODC 8.16
- CPIX 31.45
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.